DC
PFE icon

Davenport & Co’s Pfizer PFE Stock Holding History

Davenport & Co’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-13,900
Closed -$337K – 1258
2025
Q2 		$337K Buy
+13,900
New +$324K ﹤0.01% 1008

Other funds holding PFE

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
ORIO
Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Davenport & Co's PFE Position: Q2 2026 in Review

Davenport & Co increased its Pfizer (PFE) stake by 0.27% in Q2 2026, buying an estimated $31.7K and bringing the position to 446,366 shares worth $10.8M. The position accounts for 0.05% of the portfolio, ranked #247.

Davenport & Co first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $23.4M in Q4 2021. 666 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Davenport & Co held 446,366 shares of Pfizer worth $10.8M as of Q2 2026.
  • Davenport & Co bought 1,213 Pfizer shares in Q2 2026, an estimated $31.7K.
  • Pfizer made up 0.05% of Davenport & Co's portfolio in Q2 2026, its #247 holding.
  • Davenport & Co first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Davenport & Co's Pfizer position peaked at $23.4M in Q4 2021.
  • 666 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Davenport & Co's 13F filing for Q2 2026, filed 13 Jul 2026.